UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________
FORM 8‑K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 5, 2015 (February 4, 2015)
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
000-19364
|
|
62-1117144
|
|
(State or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
701 Cool Springs Boulevard
Franklin, Tennessee
|
|
37067
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(615) 614-4929
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01. Other Events.
Plastipak Dispute
Healthways, Inc. (the "Company") has previously disclosed a contractual dispute with Plastipak Packaging, Inc. ("Plastipak"). On December 30, 2014, the Company disclosed in its Current Report on Form 8-K that in connection with the trial relating to this dispute, the parties had stipulated that the Court would render a judgment in favor of Plastipak of not less than $3 million and not more than $14 million. On February 4, 2015, the Court announced an award of $7.252 million in favor of Plastipak. The amount of the award will be included in the Company's financial results for the quarter ended December 31, 2014.